IAPO Workshop on Biosimilar Medicines - Geneva, Switzerland - 2-3 May 2013
On the 2-3 May 2013, IAPO held a Workshop on Biosimilar Medicines in Geneva. The workshop brought together over 19 patients’ organization representatives and other healthcare stakeholders from around the world to participate in an exciting programme which explored the impact of biological and biosimilar medicines on patient care including issues of access and availability. The workshop was attended by healthcare stakeholders such as the European Generic Medicines Association and International Hospital Federation, as well as the sponsors of IAPO’s Biosimilar Medicines Project.
The workshop covered topics such as how biological and biosimilar medicines can address current and future needs for diagnosis, prevention and treatment, and learning and best practices to facilitate patient access to these medicines, allowing time for discussion and debate.
There were presentations from Dr Hye-Na Kang from the World Health Organization, Dr Pekka Kurki, Finnish Medicines Agency, and Michael Reilly, Alliance for Safe Biologic Medicines. The workshop ended with action planning for the future and IAPO will support patients’ organizations in further developing and implementing their action plans where possible.
IAPO also used this opportunity to gain detailed feedback regarding the Draft Updated Briefing Paper on Biosimilar Medicines which aims to provide patients’ organizations with useful and detailed information regarding biological and biosimilar medicines.
Click here for the Meeting Report. See full list of participants here.
Previous work on Biosimilar Medicines:
IAPO Biosimilars Workshop – Brussels, Belgium - 4 December 2006
On December 4 2006, IAPO held a workshop in Brussels for patient representatives and other stakeholders to provide further information and discuss the issues surrounding the growing prevalence of biotechnology medicine copies and in particular, biosimilar medicines.
The event was attended by delegates from patients’ organizations that represented different disease areas and came from across Europe, as well as representatives from professionals’ organisations, including the International Council of Nurses and the International Pharmaceutical Federation. To read more about the workshop and download the presentations, click here.
IAPO Briefing Paper on Biosimilar Medicines, 2006
IAPO has published a Briefing Paper to educate and inform patients' organizations on the introduction of biosimilar medicines. This was published in September 2006 and will be launched at the European Parliament in Brussels on the 5 December 2006.
The Briefing Paper outlines issues for consideration by patients and patients' organizations and also brings together stakeholder perspectives on the most important issues relating to the introduction of biosimilar medicines.
The Briefing Paper is being provided to over 1,000 patients' organizations around the world free of charge.
You can access the briefing paper here.
Development of the Paper has been supported financially by an unrestricted educational grant from Amgen.
Please contact firstname.lastname@example.org for further information on IAPO's work on biosimilar medicines.